Valuation : Guilin Sanjin Pharmaceutical Co., Ltd.

Market Cap 7.31B 1.09B 934M 874M 800M 1.51B 104B 1.51B 10.35B 4.05B 52.35B 4.08B 3.99B 173B P/E 2024
17x
P/E 2025 19.1x
Enterprise Value 6.1B 908M 779M 730M 668M 1.26B 86.71B 1.26B 8.64B 3.38B 43.7B 3.41B 3.33B 145B EV / Sales 2024
3.55x
EV / Sales 2025 3.46x
Free-Float
21.97%
Yield 2024
3.98%
Yield 2025 3.55%
1 day-0.24%
1 week-6.42%
Current month-5.64%
1 month-2.41%
3 months-7.11%
6 months-14.11%
Current year-11.06%
1 week 12.31
Extreme 12.31
13.63
1 month 12.31
Extreme 12.31
13.63
Current year 11.91
Extreme 11.91
14.95
1 year 11.91
Extreme 11.91
15.75
3 years 11.28
Extreme 11.28
18.35
5 years 10.59
Extreme 10.59
21.67
10 years 10.59
Extreme 10.59
21.67
Manager TitleAgeSince
Director of Finance/CFO 65 2013-12-26
President 50 2022-12-25
Corporate Officer/Principal 56 2022-12-25
Director TitleAgeSince
Chairman 50 2022-01-13
Director/Board Member 46 2019-12-25
Director/Board Member 65 2007-12-20
Date Insider Type Main position Quantity % Market Cap.
4/29/24 Buy

Chairman

148,300 0.0268%
9/29/20 Sell

Chairperson

89,100 0.0165%
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%-6.42%-19.36%-17.06% 1.09B
+1.01%+1.01%-13.78%-5.57% 13.27B
+1.98%+0.33%-35.14%-57.05% 4.97B
+1.85%-5.05%-6.75%-2.34% 4.65B
+1.58%-4.23%-1.29%-28.74% 4.04B
+1.01%+0.61%-21.17%+5.44% 3.59B
+2.21%+3.87%-6.13%-3.71% 3.46B
-0.47%-4.16%-13.69%+11.83% 3.29B
+0.86%-3.04%-19.63%-15.55% 2.43B
+1.82%-1.23%-31.46%-11.34% 1.71B
Average +1.16%-1.54%-16.84%-12.41% 4.25B
Weighted average by Cap. +1.24%-0.94%-15.51%-12.10%

Financials

2024 2025
Net sales 2.19B 326M 280M 262M 240M 453M 31.18B 454M 3.11B 1.21B 15.71B 1.23B 1.2B 52B 2.05B 304M 261M 245M 224M 422M 29.07B 423M 2.9B 1.13B 14.65B 1.14B 1.12B 48.49B
Net income 522M 77.6M 66.61M 62.36M 57.1M 108M 7.41B 108M 738M 289M 3.74B 291M 285M 12.36B 433M 64.44M 55.32M 51.79M 47.42M 89.34M 6.15B 89.59M 613M 240M 3.1B 242M 237M 10.27B
Net Debt -1.08B -161M -138M -129M -118M -223M -15.38B -224M -1.53B -599M -7.75B -604M -591M -25.65B -1.21B -180M -154M -144M -132M -249M -17.16B -250M -1.71B -668M -8.65B -675M -660M -28.62B
Logo Guilin Sanjin Pharmaceutical Co., Ltd.
Guilin Sanjin Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, manufacturing and sales of Chinese patent medicines. The Company mainly operates in the two major areas of oral and throat health and urinary health, including the prevention, self-treatment and rehabilitation of common household diseases such as cardiovascular and cerebrovascular, nervous system, respiratory system and digestive system. The Company's main products include Sanjin Tablets, Guilin Xiguashuang, Xiguashuang Throat Tablets, Xiguashuang Qingyan Lozenges, Naomaitai Capsules, Xuanyunning Tablets/Granules, Gejie Dingchuan Capsules, Yuye Jiedu Granules.
Employees
2,556
Date Price Change Volume
26-08-27 CN¥12.44 +0.24% 4,448,127
26-08-26 CN¥12.41 -1.04% 4,481,501
26-08-25 CN¥12.54 -0.24% 3,431,945
26-08-24 CN¥12.57 -4.99% 5,222,063
26-08-21 CN¥13.23 -2.86% 4,198,300

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002275 Stock